Stem cell-based therapies are a promising new avenue for treating ischemic disease and chronic wounds. Mesenchymal stem cells (MSCs) have a proven ability to augment the neovascularization processes necessary for wound healing and are widely popular as an autologous source of progenitor cells. Our lab has previously reported on PEGylated fibrin as a unique hydrogel that promotes spontaneous tubulogenesis of encapsulated MSCs without exogenous factors. However, the mechanisms underlying this process have remained unknown. To better understand the therapeutic value of PEGylated fibrin delivery of MSCs, we sought to clarify the relationship between biomaterial properties and cell behavior. Here we find that fibrin PEGylation does not dramatically alter the macroscopic mechanical properties of the fibrin-based matrix (less than 10% difference). It does, however, dramatically reduce the rate of diffusion through the gel matrix. PEGylated fibrin enhances the tubulogenic growth of encapsulated MSCs demonstrating fluid-filled lumens by interconnected MSCs. Image analysis gave a value of 4320 ± 1770 μm total network length versus 618 ± 443 μm for unmodified fibrin. PEGylation promotes the endothelial phenotype of encapsulated MSCs-compared to unmodified fibrin-as evidenced by higher levels of endothelial markers (von Willebrand factor, 2.2-fold; vascular endothelial cadherin, 1.8-fold) and vascular endothelial growth factor (VEGF, up to 1.8-fold). Prospective analysis of underlying molecular pathways demonstrated that this endothelial-like MSC behavior is sensitively modulated by hypoxic stress, but not VEGF supplementation as evidenced by a significant increase in VEGF and MMP-2 secretion per cell under hypoxia. Further gain-of-function studies under hypoxic stress demonstrated that hypoxia culture of MSCs in unmodified fibrin could increase both vWF and VE-cadherin levels to values that were not significantly different than cells cultured in PEGylated fibrin. This result corroborated our hypothesis that the diffusion-limited environment of PEGylated fibrin is augmenting endothelial differentiation cues provided by unmodified fibrin. However, MSC networks lack platelet endothelial cell adhesion molecule-1 (PECAM-1) expression, which indicates incomplete differentiation towards an endothelial cell type. Collectively, the data here supports a revised understanding of MSC-derived neovascularization that contextualizes their behavior and utility as a hybrid endothelial-stromal cell type, with mixed characteristics of both populations.
Introduction
Autologous cell-based therapies are a developing strategy to address ischemic morbidities and promote perfusion of oxygen-and nutrientdeprived tissue. Currently, common targets include sites of acute injury, large or chronic wound beds, and critical limb ischemia (Fadini et al., 2010) . For these applications, the end-goal is to achieve revascularization, which is often the rate-limiting step in wound healing (Gibot et al., 2010) . Establishing a robust blood supply better sustains the high metabolic demands of inflammation and tissue remodeling and promotes more rapid resolution of the damaged tissue (Gibot et al., 2010) . Healing outcomes have been further improved when biomaterial gels, foams, or scaffolds are co-delivered with the grafted stem cells (Kim et al., 2011) . These biomaterials serve a threefold purpose: (1) to act as a cell delivery vehicle, (2) to enhance and direct stem cell behavior, and (3) to serve as bioactive filler that physically and biochemically integrates with local tissues.
Our group has previously reported on PEGylated fibrin as a naturalsynthetic polymer composite that promotes tubulogenesis of encapsulated bone marrow-derived mesenchymal stem cells (MSCs), without added soluble factors (Zhang et al., 2010) . Here, PEGylation slows fibrinolysis and extends the therapeutic window of MSCs localized within the matrix. Additionally, bone marrow-derived MSCs serve as a readily available autologous progenitor population that are responsive to substrate cues (Lutolf et al., 2009 ) and have a proven history of enhancing angiogenic activity and wound closure (Falanga et al., 2007) . While we have previously observed a dramatic increase in tubulogenic development of MSCs in PEGylated fibrin gels (compared to fibrin) (Rytlewski et al., 2012) , the full breadth of differences in cellular behavior has not yet been characterized, nor have the underlying mechanisms. Understanding how PEGylation changes biomaterial properties is critical to understanding why MSC network development is significantly improved. Furthermore, gaining a clearer understanding of this cell-gel system will facilitate a more targeted context for its potential clinical implementation.
The series of in vitro studies presented here aims to characterize the biophysical properties of PEGylated fibrin gels and subsequent cell behavior associated with neovascularization events: lumenal space formation, production of matrix remodeling and paracrine factors, and markers of an endothelial phenotype. Possible matrix cues were then isolated to determine which cues yielded specific neovascularization events.
Methods

Materials
Low-glucose Dulbecco's modified Eagle's medium (DMEM), phosphate buffered saline (PBS), fetal bovine serum (FBS), and Gluta-MAX™-I (100×) were purchased from Invitrogen (Carlsbad, CA). Penicillin-streptomycin and trypsin/ethylenediaminetetra-acetic acid were purchased from ATCC (Manassas, VA). Sigma-Solohill microcarrier beads (MCBs) coated in porcine collagen were obtained from Sigma-Aldrich (St. Louis, MO) as well as fibrinogen and thrombin from human plasma. Linear homo-difunctional polyethylene glycol succinimidylglutarate (PEG-(SG) 2 , 3400 Da) was purchased from NOF America (White Plains, NY).
PEGylated fibrin gel fabrication
Gel fabrication followed our previously described protocol for enzymatically crosslinked PEGylated fibrin and fibrin gels (Rytlewski et al., 2012; Zhang et al., 2010) . Human fibrinogen was solubilized in PBS (without calcium or magnesium, pH 7.8) at 8 × the desired final concentration. PEG-SG 2 was similarly dissolved in PBS. Human thrombin was reconstituted in nanopure ddH 2 O to 100 U/mL and diluted to 25 U/mL with 40 mM CaCl 2 . Gel components were sterilized with 0.22 μm syringe filters. Gel components were mixed in the following order (volume ratio): (1) fibrinogen, (1) PEG-SG 2 , (2) PBS for rheology or MSC-seeded MCBs for cell studies (4) thrombin. Gelation was finalized at 37°C for 15 min before rinsing with PBS (with calcium and magnesium).
Rheology
Gels were prepared without cells in 40 mm diameter non-stick molds for a parallel plate rheometer configuration and were kept hydrated with PBS prior to and during testing. Strain sweeps were measured from 0.1-2.5% at 15 rad/s at a plate temperature of 37°C. Storage and loss moduli were reported for statistical comparison at 1% strain.
Cryogenic scanning electron microscopy
Cell-free gels were prepared in small-volume molds and kept hydrated in PBS (with calcium and magnesium). Gels were briefly rinsed in ddH 2 O before mounting on a cryogenic SEM stage with carbon tape. Mounted gels were then snap-frozen in liquid nitrogen and fractured with a scalpel to expose cross-sectional structures. Gels were transferred to the cryo prep unit within a vacuum cryo transfer shuttle (Leica EM VCT100) to minimize crystal formation from air exposure. In the prep unit (Leica EM MED020), the stage temperature was raised from − 140°C to − 110°C to sublimate water crystals from the gels. Samples were then sputter coated with palladium and shuttle-transferred to the SEM for imaging. The SEM stage was kept at − 120°C to − 123°C for the duration of imaging.
Diffusional characterization
Syringes (without the plunger) were used as molds for containing fibrin or PEGylated fibrin gels and the test solute. Cell-free gels (500 μL volume) were formed at the 0 cm 3 demarcation of the syringe barrel, gelled to completion at 37°C, and rinsed with an equal volume of PBS. After the PBS was aspirated, the slip-tips of the syringes were carefully removed to expose the gel bottoms. Removal of the slip-tips ensured that diffusivity of the test solute was limited by the gel and not by capillary resistance of the solvent through the syringe. Syringes were vertically fixed in place and 500 μL of 2.5 mg/mL 10 kDa dextran-Texas Red conjugate (Molecular Probes; Eugene, OR) was added directly on top of the gels. While fluorescence was not utilized, the purple appearance of Texas Red dye provided clear visualization of the dextran. Time-lapse photos of dye diffusion were taken every 15 min for 7 h.
Expansion and maintenance of cells
Human bone marrow-derived mesenchymal stem cells (MSCs; Lonza; Basel, Switzerland) were cultured according to the manufacturer's specifications with growth medium in tissue culture-treated plastic flasks at 5000 cells/cm 2 . growth medium consisted of DMEM supplemented with 10% FBS, 1% penicillin-streptomycin, and 2 mM GlutaMAX™-I. MSCs were tested by the manufacturer for trilineage differentiation potential and for positive expression of CD105, CD166, CD29, and CD44; cells were negative for CD14, CD34, and CD45. Population purity was greater than 95%. For gel cultures, cells were seeded on MCBs according to our previously described protocol, based on the modified bead-outgrowth assay developed by Nakatsu and Hughes (Nakatsu et al., 2007; Nakatsu and Hughes, 2008; Nehls and Drenckhahn, 1995) . Briefly, cells at passages 4-6 were trypsinized, centrifuged into a pellet, and resuspended in media at a minimum concentration of 1.4 × 10 5 cells/mL.
MSCs were seeded at 7.0 × 10 4 cells/mg MCB. Cells and MCBs were gently agitated every 30 min over 4 h and then transferred to ultralow adhesion 6-well plates for further coating overnight. Cell-seeded MCBs were strained through a 70 μm mesh and resuspended in 300 μL growth media/mg MCB prior to encapsulation in gels. Gels were thoroughly rinsed with growth media to remove cytotoxic unreacted PEG-SG 2 . Gel culture was carried out to day 7 with growth media unless otherwise specified.
Small molecules for functional assays
For some experimental groups, small molecules, proteins, or peptides were added to culture media. the concentration used, the experimental study in which it was applied, and the manufacturer's information.
Hypoxic cell culture
Where indicated, MSCs were also cultured under 1% O 2 and 2% O 2 using a hypoxia chamber (Stemcell Technologies; Tukwila, WA), generously loaned to us by Dr. Aaron Baker. Hypoxic gas mixes were composed of 5% CO 2 , 1% or 2% O 2 , and N 2 balance (Praxair; Danbury, CT). Cell cultures were environmentally isolated inside the hypoxia chamber with an open petri dish of water for humidity and kept at 37°C. The chamber was purged with hypoxic gas for 5 min and then purged again 90 min later to evacuate any residual oxygen. Thereafter, the chamber was purged every 48 h to maintain hypoxic cultures unless opened for assay endpoints.
Fluorescent cell staining for visualizing vacuolar compartments
Texas Red-conjugated dextran (10 kDa; Molecular Probes; Eugene, OR) was added to the media of gel cultures as a cell-impermeable dye for pinocytic uptake (Davis and Camarillo, 1996) . For day 7 endpoint cultures, 1.25 mg/mL of dextran was added on day 4; for day 10 endpoint cultures, dextran was added on day 7. After cultures were terminated, MSCs were fixed and additionally stained with FITCphalloidin (F-actin) and DAPI (nuclei).
Fluorescent cell staining for morphological quantification
On day 7 of gel culture, the samples were thoroughly rinsed with PBS (with calcium and magnesium) for 1 h. Calcein AM (Invitrogen; Carlsbad, CA) was added at 10 μM for 1 h to stain the cytoplasm of live cells. samples were again rinsed with PBS and then fixed with 4% neutral-buffered formalin for 30 min. samples underwent a final PBS rinse and stored at 4°C overnight for imaging the next day.
Two-photon microscopy
Fluorescent z-stacks were collected of MSC outgrowth from individual microcarrier beads with an Ultima Multiphoton Microscopy System (Prairie Technologies; Middleton, WI). Simultaneous twophoton excitation of multiple fluorophores was achieved with a tunable Ti:sapphire laser (Spectra-Physics Mai Tai HP; Newport; Irvine, CA) set to 720 nm. Z-slice thickness was adjusted to maintain isometric voxel dimensions. A thickness of 500-700 μm was imaged along the z-axis for each image stack.
Three-dimensional morphological quantification
Image processing and three-dimensional morphological quantification followed our recently described method (Rytlewski et al., 2012) . As before, z-stacks were preprocessed in ImageJ (Release 1.2.4; ImageJ Plugin Project) and loaded into 3D Slicer (Release 3.6, 64-bit Linux). The Vascular Modeling Toolkit in 3D Slicer was used for image segmentation and 3D model generation. Centerline tracings of 3D models were exported as large data clouds of x,y,z coordinates with corresponding model radii. The data cloud was processed in MATLAB (Release 2008a for Macintosh) to calculate the average 3D network length per MCB.
Cell proliferation
The CellTiter 96® Aqueous One Solution Cell Proliferation Assay (Promega; Madison, WI) was used to quantify the cell content of gels. On days 1, 3, 5, and 7 of gel culture, the culture supernatant was removed and saved for secreted protein analysis. Fresh growth media + 20% (v/v) CellTiter 96® solution was then added for 4 h.
Supernatants were transferred in triplicate to a 96-well plate. Absorbance was measured at 490 nm with a microplate reader (BioTek Synergy HT Multi-Mode Microplate Reader; Winooski, VT).
Secreted protein detection by ELISA
Quantikine ELISA kits (R&D Systems; Minneapolis, MN) were procured for VEGF, matrix metalloproteinase-2 (MMP-2), and MMP-9. Supernatants collected from cell proliferation samples were assayed according to the manufacturer's instructions. Optical density was measured at 490 nm. Secreted protein quantities were normalized to cell number using the results of the matched-sample MTS assay.
Cellular protein detection by Western blot
Cells in gels were lysed with RIPA buffer (Santa Cruz Biotechnology; Dallas, TX) and homogenized with a soft tissue grinder (OMNI International; Kennesaw, GA). Cell-gel lysates were passed through a 21-gauge needle 20 × for further homogenization and solid gel remnants were removed through centrifugation. Supernatants were denatured in Laemmli buffer with 5% β-mercaptoethanol at 95°C for 5 min. Denatured samples were separated with 10% mini-Protean® TGX™ precast gels (Biorad; Hercules, CA) at 20 μg protein per gel lane and blotted onto PVDF membranes. membranes were blocked for 1 h at room temperature with 5% (w/v) non-fat milk in TBST and then incubated overnight with a primary antibody at 4°C. membranes were rinsed with TBST and incubated with an HRP-conjugated secondary antibody for 1 h at room temperature. After a second set of TBST rinses, 3 mL of SuperSignal West Dura Chemiluminescent Substrate (Pierce Thermo Fisher Scientific; Rockford, IL) was added per membrane for 5 min prior to image capture with a FluorChem CCD system (ProteinSimple; Santa Clara, CA). chemiluminescent signal was quantified with AlphaView software for statistical analysis. For a list of antibodies and their dilutions, refer to Table 2 .
Statistical analysis
A one-or two-way analysis of variance was used to determine significance between experimental groups. Where significance was found, post-hoc tests were performed to further determine specific relationships of statistical significance. Tukey's correction for multiple comparisons was applied where appropriate. P-values less than 0.05 were considered statistically significant. All statistical tests were completed in Prism (Version 6.0 for Mac OS X; GraphPad, La Jolla, CA).
Results
Macro-and microscopic changes associated with fibrin PEGylation
Rheological characterization of PEGylated fibrin gels in Fig. 1A showed little change in their viscoelastic properties over unmodified fibrin gels when matched by fibrin concentration. At 10 mg/mL, fibrin gels (10F) had a statistically significant increase in their elastic modulus over PEGylated fibrin (10P) but the magnitude of this increase was less than 10% of the storage modulus. Both PEGylated fibrin and fibrin gels demonstrated increasing elastic moduli with increasing fibrin concentration, corresponding to the crosslinking density of the matrix (approximately 50 Pa, 75 Pa and 125 Pa for 5 mg/mL, 7.5 mg/mL and 10 mg/mL 10P, respectively). Despite similar mechanical properties, cryo-SEM (Figs. 1B-E) revealed remarkable differences in the fibrin gel microstructure introduced by PEGylation. Unmodified fibrin (10F) had a stereotypical fibrous and sponge-like appearance. PEGylated fibrin (10P), in contrast, had non-porous amorphous layers interspersed within the fibrous architecture. This amorphous quality is associated with a significant change in fibrin's diffusional characteristics. In Fig. 1F , time-lapse photography of labeled 10 kDa dextran showed both slowed diffusion of the dextran solute and slower filtration of the PBS solvent through PEGylated fibrin (10P) over unmodified fibrin (10F) gels.
MSC in PEGylated fibrin form hollow tubes with endothelial markers
We have previously reported that networks formed by MSCs in PEGylated fibrin were significantly longer than those encouraged by fibrin alone (Rytlewski et al., 2012) , indicating that PEGylated fibrin is superior in promoting tubulogenesis. Here, we further characterize important neovascular features of MSC networks and seek to correlate these features with the material properties of PEGylated fibrin matrices. The presence of intra-and inter-cellular vacuolar compartments is the first step in lumen formation and was the first key characteristic we examined. Based on a lumenization study by George Davis's group on endothelial network development (Davis and Camarillo, 1996) , gel culture media were doped with membrane-impermeable 10 kDa dextran-Texas Red. Pinocytosed vesicles (containing the labeled dextran) are known to fuse with vacuolar compartments (K. Bayless and Davis, 2002) . Hence, these lumenal spaces, if present, can be visualized by the intracellular localization of the fluorescent dextran. Fluorescent microscopy of MSC networks in PEGylated fibrin (10P)
showed large intracellular compartments of fluorescent dextran that spanned multiple cell lengths ( Figs. 2A-C) , suggesting that intercellular vacuole fusion had occurred. These large vacuolar spaces with non-overlapping nuclei and narrow tube diameter are highly reflective of cell-hollowing lumen assembly associated with small capillary development (Lubarsky and Krasnow, 2003) . In contrast, lower magnification views of cells in fibrin gels (10F, Fig. 2D ) do not demonstrate interconnected networks relative to similar views of cells in PEGylated fibrin (10P, Fig. 2E ).
Mediators of MSC motility in PEGylated fibrin (10P) during tubulogenesis and lumenization were identified by examining components of the matrix-integrin-cytoskeletal (MIC) axis . As in normal endothelial network development, MSCs exhibited a strong dependence on microtubule assembly and integrinmediated binding. In Figs. 3B-D & G, colchicine (a tubulin inhibitor) caused a more dramatic decrease in network assembly than cytochalasin B (an actin inhibitor), although both were statistically significant. Additionally, cyclic-RGD inhibition of cell motility (Figs. 3E-G) effectively eliminated network outgrowth, while control peptides of cyclic-RGE were not statistically different from controls. This result implicates αvβ3 and α5β1 as likely integrins responsible for MSC adhesion to PEGylated fibrin and is consistent with current literature regarding how endothelial cells interact with fibrin-based matrices.
Secreted and cellular proteins were analyzed to provide evidence of endothelial-like MSC behavior. Total protein secretion of VEGF and MMP-2 was higher in fibrin gels than in PEGylated fibrin (not shown). However, the metabolic assay indicated a slower growth rate of MSCs in PEGylated fibrin (10P, Fig. 3H ). When protein production was normalized to cell number, we found that MSCs in PEGylated fibrin (10P) secreted significantly larger quantities of early (days 1 and 3) VEGF and late (days 3, 5 and 7) MMP-2 than MSCs in fibrin alone (10F, Figs. 3I & J) . Western blot of cellular proteins showed that MSCs in both matrices (fibrin and PEGylated fibrin) under normoxia also expressed vWF and VE-cadherin proteins (Fig. 5I) , which are considered highly specific to endothelial populations (Pusztaszeri et al., 2006) . Interestingly, PECAM-1 protein expression was not detected from either matrix (Supplemental material Fig. 1 ).
Hypoxia activation is more important to MSC proliferation and secretion than direct VEGF stimulation
Potential stimuli from the microenvironment were tested to pinpoint the key pathway responsible for catalyzing MSC transformation towards an endothelial-like cell type. The sensitivity of MSC tubulogenesis in PEGylated fibrin to chemically simulated hypoxia (CoCl 2 ) (Piret et al., 2002) , true hypoxia (1% O 2 ), and soluble VEGF (Figs. 4A-D) was assessed by quantification of network development, cell proliferation, and angiogenic protein production.
Induction of cellular hypoxia with 1% O 2 was confirmed by ELISA for HIF-1α protein (Fig. 4E) ; protein was normalized to DNA content of the sample to account for different cell proliferation rates under normoxic and hypoxic conditions. Significant upregulation was demonstrated under 1% hypoxia in PEGylated fibrin (10P) versus normoxia. As diagrammed in Fig. 4F , upregulation of HIF-1α is specifically known to stimulate neovascularization processes. Quantification of MSC network lengths (Fig. 4G ) indicated that VEGF, CoCl 2 , and 1% O 2 all resulted in shorter networks than the control group (10P), though 1% O 2 was not statistically significant. Growth rate quantification, however, revealed that 1% O 2 significantly reduced the number of MSCs cultured in 10P from day 3 onward (Fig. 4H) . When secreted VEGF and MMP-2 were again analyzed, we found that only 1% O 2 significantly increased the production of both proteins over the control normoxic group (Figs. 4I & J) . Others have similarly reported a lack of MSC sensitivity to soluble VEGF and emphasized the importance of other variables, such as cell density, over supplemental growth factors (Galas and Liu, 2014) . From this study, we concluded that MSCs are sensitive to hypoxic stress in PEGylated fibrin gels. Despite limited cell proliferation, hypoxia did not significantly hinder the ability of these cells to form tubular networks and encouraged further production of secreted proteins important in neovascularization.
Fibrin bioactivity induces baseline endothelial marker expression
After examining the morphological and functional consequences of hypoxia in PEGylated fibrin matrices, we sought to refine the specific roles of hypoxia and matrix cues on the expression of endothelial markers in MSC networks. This aim was subdivided into two experiments: a 2D study under normoxia to establish baseline behavior and a 3D study under both normoxia and hypoxia to ascertain any gain-of-function changes.
In the first experiment, MSCs were cultured as a two-dimensional monolayer on top of a thin gel (either 4 mg/mL fibrin, 4F, or 4 mg/mL PEGylated fibrin, 4P), eliminating gel-associated diffusion gradients (Sahai et al., 2012) . Collagen was added as a third experimental group to control for fibrin content (4 mg/mL collagen, 4C). Western blot was performed in triplicate ( Fig. 5F ) and the chemiluminescent signal was normalized to β-actin for vWF and VE-cadherin proteins. Statistical analysis revealed that MSCs on PEGylated fibrin (4P) and fibrin gels (4F) expressed similar quantities of both endothelial markers in 2D (Figs. 5G & H) . MSCs on collagen (4C), however, had significantly diminished endothelial protein expression compared to MSCs on PEGylated fibrin. These results imply that (1) PEGylation does not interfere with the bioactivity of fibrin proteins and (2) fibrin alone is responsible for a basal level of endothelial-like MSC character. 
PEGylation-associated hypoxic stress synergistically enhances fibrin cues
In the second experiment, typical 3D culture of MSCs in PEGylated fibrin (10P) and fibrin (10F) were compared for endothelial marker expression under normoxia (Figs. 5A & B, I-K) . Western blot for vWF and VE-cadherin showed that PEGylated fibrin encourages significantly greater expression of both markers over unmodified fibrin alone (Figs. 5J & K) . Since the 2D study indicated that fibrin content encourages similar basal levels of vWF and VE-cadherin regardless of PEGylation, the new difference observed in 3D culture can be attributed to PEGylation-associated changes to the matrix environment. When both 3D matrices were cultured under 1% O 2 , MSC expression of vWF and VE-cadherin was once again similar (Figs. 5C & D, L-N) . We hypothesize that re-equilibration of the MSC endothelial character under 1% O 2 is reflective of fibrin-encapsulated MSCs gaining function (Majumdar et al., 2013; Razban et al., 2012) , PEGylated fibrin-encapsulated MSCs experiencing diminished benefits from applied hypoxia, or a combination of both.
Morphological quantification was again applied to compare network lengths. Again, under normoxia and hypoxia, cells in fibrin (10F) remained significantly shorter than cells in PEGylated fibrin (10P, Fig. 5E ). However, even with hypoxic stress and increased endothelial marker expression, MSCs in fibrin networks were still unable to form substantial networks. Additionally, both hypoxic groups were statistically similar to their normoxic controls. While this result is consistent with the study shown in Fig. 4 , we would ordinarily expect an increase in endothelial marker expression and angiogenic proteins with an increase in network length (Kumar et al., 2011; Simionescu et al., 2012) . This suggests that there is an additional feature of PEGylated fibrin that leads to extensive network formation that may be independent of the endothelial-like protein expression of MSCs.
Discussion
The studies presented here sought to (1) characterize the extent of endothelial-like character in MSC tubulogenesis and (2) understand how the PEGylated fibrin matrix influences these cellular outcomes. Material characterization showed that PEGylated fibrin is associated with increased amorphous over fibrous gel character and restricted diffusion, which previous studies have linked with increased MSC tubulogenesis. Current studies find that, like normal endothelium, MSC networks in PEGylated fibrin are also hollow, upregulate VEGF and MMP-2 production, and express vWF and VE-cadherin. Our studies have identified that fibrin is responsible for a basal endothelial profile while hypoxia serves to enhance differentiation of MSCs further towards an endothelial phenotype. Robust vascular morphology, on the other hand, was most significantly associated with fibrin PEGylation rather than the biochemical nature of the matrix or the oxygen tension in culture. These results suggest that morphology depends upon a physical matrix quality apart from typical biochemical cues. We hypothesize that guidance tunnels, previously identified in normal neovascular sprouts, are able to remain patent in semi-amorphous PEGylated fibrin and have a tendency to collapse in fibrin. Unmodified fibrin exhibits a higher loss tangent at the same concentration, leading to a greater degree of viscous flow for the same value of storage modulus. This theory is supported by the time-lapse video of MSC tubulogenesis (Supplemental Fig. 2 ) where we observe some cells retracing tunneled paths. The lack of PECAM-1 expression, however, led us to question the extent of MSC differentiation towards an endothelial cell type (Pusztaszeri et al., 2006 ). An adjunct study (Supplemental Fig. 3 populations (Ghajar et al., 2010) . Endothelial cells have a welldocumented need for a supporting stromal population to fully form extended and stable networks; co-cultures are typically employed to rescue their lack of endogenously produced MMPs. Fibroblasts and MSCs have each been used as pericyte support cells in such cases (Athanassopoulos et al., 2012; Ghajar et al., 2010; Lesman et al., 2011; Oberringer et al., 2007) . Interestingly, fibroblasts (used as a negative control in this adjunct study) were also able to match the ability of MSCs to form networks and express vascular markers, suggesting two possibilities: that fibroblasts possess a greater degree of phenotypic plasticity than previously anticipated (Alt et al., 2011; Blasi et al., 2011) or that a MSC networks retain fibroblastic features of their undifferentiated state alongside newly acquired endothelial behaviors. To our knowledge, only one report has previously described the ability of fibroblasts to adopt endothelial character; their in vitro methodology employed traditional monolayer culture supplemented by growth factors (Karlsson et al., 2009 ). In literature, another neovascularization process has been similarly described in which cells are similarly characterized as VE-cadherin (+) but PECAM-1 (−) and highly dependent on MMP-2 production: vasculogenic mimicry (Folberg and Maniotis, 2004; Hendrix et al., 2001; Hess et al., 2003) . Vasculogenic mimicry is a unique process whereby dense tumors overcome hypoxic stress by creating tumorlined pseudovasculature. Described by Maniotis et al. in (1999) , vasculogenic mimicry was the first evidence demonstrating that non-endothelialized microvessels are capable of transporting blood without clotting (Maniotis et al., 1999) . In terms of tissue engineering strategies, vasculogenic mimicry represents a neovascularization process where a single stromal-type population is driven (primarily) by matrix cues and hypoxic stress towards endothelial-like structure and function (Vartanian, 2012; Zhao et al., 2012) . Although these nonendothelialized networks are more leaky and less efficient than normal vasculature, they are functional enough to facilitate blood transport and tumor survival.
While we did not look at an exhaustive profile of endothelial markers (vWF, VE-cadherin, PECAM-1, VEGF and MMP-2 in this study), the parallels between MSC tubulogenesis and vasculogenic mimicry provide a novel perspective towards understanding lesserdescribed stromal cell states. In cancer, these hybrid cell states are well documented. In fact, the classical epithelial-to-mesenchymal transition is often classified as "partial," where epithelial cells exhibit increased migration without complete loss of cell-cell adhesion and polarity (Kalluri and Weinberg, 2009 ). Here, we describe adult stem cells exhibiting increased endothelial characteristics while retaining some of their original fibroblastic traits. We propose that transitional phenotypes in stem cell biology may similarly be a third state with functional utility and worthy of further investigation.
In regard to therapeutic neovascularization, endothelial-like networks may provide a clinically feasible pseudovasculature for temporarily sustaining grafts until the host vasculature is able to infiltrate and remodel tissue. The ability of fibroblasts to match endothelial-like MSC behavior suggests that this mechanism of tubulogenesis may be shared amongst other cells of stromal lineage. Tubulogenesis is a major mechanism of normal embryological development and organogenesis as well as a potent mechanism of metastatic invasion (Lubarsky and Krasnow, 2003; Nagle and Cress, 2011) . However, stromal tubulogenesis in non-diseased adult biology lacks documentation; further studies would be necessary to determine whether this cell behavior is an artifact of in vitro culture or simply a rare natural phenomenon. If tubulogenesis is in fact a latent but inducible stromal function, the work here has the potential to open up new cell sources as therapeutically valuable for neovascularization strategies.
Supplementary data to this article can be found online at http://dx. doi.org/10.1016/j.mvr.2015.02.005.
Authorship contributions
JAR is the primary contributor in experimental design, execution, and manuscript preparation. MAA assisted in wet lab procedures while EWL performed computational analyses for morphological quantification. LJS is the primary investigator: she advised on experimental decisions and assisted in the manuscript preparation process.
Ethical standards
Experiments described within this manuscript comply with the current laws of the United States of America, in which they were performed.
